Effects of cyanocobalamin and its combination with morphine on neuropathic rats and the relationship between these effects and thrombospondin-4 expression
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Thrombospondin-4 (TSP4) upregulates in the spinal cord following peripheral nerve injury and contributes to the development of neuropathic pain (NP). We investigated the effects of cyanocobalamin alone or in combination with morphine on pain and the relationship between these effects and spinal TSP4 expression in neuropathic rats. Methods: NP was induced by chronic constriction injury (CCI) of the sciatic nerve. Cyanocobalamin (5 and 10 mg/kg/day) was administered 15 days before CCI and then for 4 and 14 postoperative days. Morphine (2.5 and 5 mg/kg/day) was administered only post-CCI. Combination treatment included cyanocobalamin and morphine, 10 and 5 mg/kg/day, respectively. All drugs were administered intraperitoneally. Nociceptive thresholds were detected by esthesiometer, analgesia meter, and plantar test, and TSP4 expression was assessed by western blotting and fluorescence immunohistochemistry. Results: CCI decreased nociceptive thresholds in all tests and induced TSP4 expression on the 4th postoperative day. The decrease in nociceptive thresholds persisted except for the plantar test, and the increased TSP4 expression reversed on the 14th postoperative day. Cyanocobalamin and low-dose morphine alone did not produce any antinociceptive effects. High-dose morphine improved the decreased nociceptive thresholds in the esthesiometer when administered alone but combined with cyanocobalamin in all tests. Cyanocobalamin and morphine significantly induced TSP4 expression when administered alone in both doses for 4 or 14 days. However, this increase was less when the two drugs are combined. Conclusions: The combination of cyanocobalamin and morphine is more effective in antinociception and partially decreased the induced TSP4 expression compared to the use of either drug alone.
Abstract
Background: Thrombospondin-4 (TSP4) upregulates in the spinal cord following peripheral nerve injury and contributes to the development of neuropathic pain (NP). We investigated the effects of cyanocobalamin alone or in combination with morphine on pain and the relationship between these effects and spinal TSP4 expression in neuropathic rats. Methods: NP was induced by chronic constriction injury (CCI) of the sciatic nerve. Cyanocobalamin (5 and 10 mg/kg/day) was administered 15 days before CCI and then for 4 and 14 postoperative days. Morphine (2.5 and 5 mg/kg/day) was administered only post-CCI. Combination treatment included cyanocobalamin and morphine, 10 and 5 mg/kg/day, respectively. All drugs were administered intraperitoneally. Nociceptive thresholds were detected by esthesiometer, analgesia meter, and plantar test, and TSP4 expression was assessed by western blotting and fluorescence immunohistochemistry. Results: CCI decreased nociceptive thresholds in all tests and induced TSP4 expression on the 4th postoperative day. The decrease in nociceptive thresholds persisted except for the plantar test, and the increased TSP4 expression reversed on the 14th postoperative day. Cyanocobalamin and low-dose morphine alone did not produce any antinociceptive effects. High-dose morphine improved the decreased nociceptive thresholds in the esthesiometer when administered alone but combined with cyanocobalamin in all tests. Cyanocobalamin and morphine significantly induced TSP4 expression when administered alone in both doses for 4 or 14 days. However, this increase was less when the two drugs are combined. Conclusions: The combination of cyanocobalamin and morphine is more effective in antinociception and partially decreased the induced TSP4 expression compared to the use of either drug alone.
참고문헌 (48)
- "IASP terminology:neuropathic pain" (2021)[URL]
- Bouhassira D, "The multiple challenges of neuropathic pain", Neurosci Lett, 702, pp.6~10 (2019)
- Zilliox LA, "Neuropathic pain", Continuum (Minneap Minn), 23(2, Selected Topics in Outpatient Neurology), pp.512~532 (2017)
- Meacham K, "Neuropathic pain: central vs. peripheral mechanisms", Curr Pain Headache Rep, 21, pp.28~ (2017)
- Adams JC, "The thrombospondins", Cold Spring Harb Perspect Biol, 3, pp.a009712~ (2011)
- Bornstein P, "Thrombospondins as matricellular modulators of cell function", J Clin Invest, 107, pp.929~934 (2001)
- Kim DS, "Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states", J Neurosci, 32, pp.8977~8987 (2012)
- Zeng J, "Thrombospondin-4 contributes to spinal cord injury-induced changes in nociception", Eur J Pain, 17, pp.1458~1464 (2013)
- Ossipov MH, "Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure", Biopolymers, 80, pp.319~324 (2005)
- Hosseinzadeh H, "Anti-nociceptive and anti-inflammatory effects of cyanocobalamin(vitamin B12)against acute and chronic pain and inf lammation in mice", Arzneimittelforschung, 62, pp.324~329 (2012)
- Xu G, "A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia", Pain Med, 14, pp.884~894 (2013)
- Suzuki K, "Electrospun nanofiber sheets incorporating methylcobalamin promote nerve regeneration and functional recovery in a rat sciatic nerve crush injury model", Acta Biomater, 53, pp.250~259 (2017)
- Zhang M, "Inhibition of hyperpolarization-activated cation current in medium-sized DRG neurons contributed to the antiallodynic effect of methylcobalamin in the rat of a chronic compression of the DRG", Neural Plast, 2015, pp.197392~ (2015)
- Smith HS, "Management of neuropathic pain—current insights and future perspectives", US Neurol, 8, pp.57~61 (2012)
- Letizia Mauro G, "Efficacy and tolerability of a fixed dose combination of cortex phospholipid liposomes and cyanocobalamin for intramuscular use in peripheral neuropathies", Minerva Med, 110, pp.455~463 (2019)
- Buesing S, "Vitamin B12 as a treatment for pain", Pain Physician, 22, pp.E45~E52 (2019)
- Bennett GJ, "A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man", Pain, 33, pp.87~107 (1988)
- Lowry OH, "Protein measurement with the Folin phenol reagent", J Biol Chem, 193, pp.265~275 (1951)
- Austin PJ, "Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats", J Vis Exp, (61), pp.3393~ (2012)
- Tsai YC, "Tramadol relieves thermal hyperalgesia in rats with chronic constriction injury of the sciatic nerve", Fundam Clin Pharmacol, 14, pp.335~340 (2000)
- Robinson I, "Stability of neuropathic pain symptoms in partial sciatic nerve ligation in rats is affected by suture material", Neurosci Lett, 373, pp.125~129 (2005)
- Maves TJ, "Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man", Pain, 54, pp.57~69 (1993)
- Ro SL, "The role of the saphenous nerve in experimental sciatic nerve mononeuropathy produced by loose ligatures : a behavioural study", Pain, 52, pp.359~369 (1993)
- Bell AM, "The repeatability of behaviour : a meta-analysis", Anim Behav, 77, pp.771~783 (2009)
- Park J, "Central mechanisms mediating thrombospondin-4-induced pain states", J Biol Chem, 291, pp.13335~13348 (2016)
- Obata H, "Activation of astrocytes in the spinal cord contributes to the development of bilateral allodynia after peripheral nerve injury in rats", Brain Res, 1363, pp.72~80 (2010)
- Chiang CY, "Role of astrocytes in pain", Neurochem Res, 37, pp.2419~2431 (2012)
- Pan B, "Painful nerve injury upregulates thrombospondin-4 expression in dorsal root ganglia", J Neurosci Res, 93, pp.443~453 (2015)
- Li KW, "Trigeminal nerve injuryinduced thrombospondin-4 up-regulation contributes to orofacial neuropathic pain states in a rat model", Eur J Pain, 18, pp.489~495 (2014)
- Crosby ND, "Thrombospondin-4 and excitatory synaptogenesis promote spinal sensitization after painful mechanical joint injury", Exp Neurol, 264, pp.111~120 (2015)
- Deng XT, "B vitamins potentiate acute morphine antinociception and attenuate the development of tolerance to chronic morphine in mice", Pain Med, 18, pp.1961~1974 (2017)
- Qian C, "Peripheral nerve injury-induced astrocyte activation in spinal ventral horn contributes to nerve regeneration", Neural Plast, 2018, pp.8561704~ (2018)
- Hoffman JR, "Thrombospondin expression in nerve regeneration I. Comparison of sciatic nerve crush, transection, and long-term denervation", Brain Res Bull, 48, pp.413~420 (1999)
- Zhang M, "Methylcobalamin : a potential vitamin of pain killer", Neural Plast, 2013, pp.424651~ (2013)
- Holtman JR Jr, "Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain", Eur J Pharmacol, 648, pp.87~94 (2010)
- Raghavendra V, "The role of spinal neuroimmune activation in morphine tolerance", hyperalgesia in neuropathic and sham-operated rats, 2002, pp.22, 9980~9989
- Song P, "The involvement of glial cells in the development of morphine tolerance", Neurosci Res, 39, pp.281~286 (2001)
- Hutchinson MR, "Opioid-induced glial activation : mechanisms of activation and implications for opioid analgesia, dependence, and reward", ScientificWorldJournal, 7, pp.98~111 (2007)
- Park JF, "The EGF-LIKE domain of thrombospondin-4 is a key determinant in the development of pain states due to increased excitatory synaptogenesis", J Biol Chem, 293, pp.16453~16463 (2018)
- Phamduong E, "Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes", ACS Chem Neurosci, 5, pp.106~114 (2014)
- Ikeda H, "Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation", J Biol Chem, 285, pp.38415~38427 (2010)
- Ghazanfari S, "Effect of cyanocobalamin(vitamin B12)in the induction and expression of morphine tolerance and dependence in mice", Drug Res (Stuttg), 64, pp.113~117 (2014)
- Gomes FC, "Glial fibrillary acidic protein(GFAP) : modulation by growth factors and its implication in astrocyte differentiation", Braz J Med Biol Res, 32, pp.619~631 (1999)
- Jones EV, "Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease", Neural Plast, 2014, pp.321209~ (2014)
- 전영훈, "Spinal Gap Junction Channels in Neuropathic Pain", The Korean Journal of Pain, 28(4), pp.231~235 (2015), 대한통증학회
- Garrison CJ, "Staining of glial fibrillary acidic protein(GFAP)in lumbar spinal cord increases following a sciatic nerve constriction injury", Brain Res, 565, pp.1~7 (1991)
- Noble M, "Long-term opioid management for chronic noncancer pain", Cochrane Database Syst Rev, 2010, pp.CD006605~ (2010)
- Scholz J, "The IASP classification of chronic pain for ICD-11 : chronic neuropathic pain", Pain, 160, pp.53~59 (2019)